Washington, DC - Fentanyl, the synthetic drug that is driving a nationwide overdose epidemic, is not only a killer. It’s also a shape shifter. Illicit chemists are constantly cooking up new forms of fentanyl, each with a slightly different chemical structure, stymieing law enforcement and putting users at greater risk.

Washington, DC - Following yesterday’s announcement by J.M Smucker, Ian Conner, Deputy Director of the Bureau of Competition, made this statement:

Washington, DC - The U.S. Food and Drug Administration today authorized the Personal Genome Service Genetic Health Risk (GHR) Report for BRCA1/BRCA2 (Selected Variants). It is the first direct-to-consumer (DTC) test to report on three specific BRCA1/BRCA2 breast cancer gene mutations that are most common in people of Ashkenazi (Eastern European) Jewish descent. These three mutations, however, are not the most common BRCA1/BRCA2 mutations in the general population.

Washington, DC - Today, the U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR HIV).Trogarzo is administered intravenously once every 14 days by a trained medical professional and used in combination with other antiretroviral medications.

Jacksonville, Florida - On Monday morning, Facebook announced that it had upgraded its link structure to include HSTS preloading. This is great news for a more secure internet as it will help to continue the proliferation of encryption across the internet.

Atlanta, Georgia - A former employee of a U.S. government contractor in Afghanistan pleaded guilty today to accepting illegal kickbacks from an Afghan subcontractor in return for his assistance in obtaining subcontracts on U.S. government contracts.